NAM

Needelman Asset Management Portfolio holdings

AUM $46M
This Quarter Return
+3.71%
1 Year Return
+8.27%
3 Year Return
+30.64%
5 Year Return
+75.02%
10 Year Return
AUM
$40.7M
AUM Growth
+$40.7M
Cap. Flow
+$821K
Cap. Flow %
2.02%
Top 10 Hldgs %
36.13%
Holding
38
New
1
Increased
11
Reduced
16
Closed

Sector Composition

1 Healthcare 26.59%
2 Financials 22.27%
3 Technology 15.05%
4 Consumer Staples 11.59%
5 Industrials 10.72%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BAC icon
1
Bank of America
BAC
$376B
$1.62M 3.97% 63,836 -7,300 -10% -$185K
UNH icon
2
UnitedHealth
UNH
$281B
$1.58M 3.89% 8,077 -980 -11% -$192K
ELV icon
3
Elevance Health
ELV
$71.8B
$1.55M 3.8% 8,140 -730 -8% -$139K
MSFT icon
4
Microsoft
MSFT
$3.77T
$1.54M 3.78% 20,690 -975 -5% -$72.6K
JPM icon
5
JPMorgan Chase
JPM
$829B
$1.5M 3.69% 15,743 -115 -0.7% -$11K
ABT icon
6
Abbott
ABT
$231B
$1.43M 3.51% 26,782
MKL icon
7
Markel Group
MKL
$24.8B
$1.43M 3.5% 1,335 -5 -0.4% -$5.34K
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.4M 3.44% 7,645 -50 -0.6% -$9.16K
HON icon
9
Honeywell
HON
$139B
$1.39M 3.42% 9,831 -135 -1% -$19.1K
JNJ icon
10
Johnson & Johnson
JNJ
$427B
$1.27M 3.13% 9,795 -40 -0.4% -$5.2K
VYX icon
11
NCR Voyix
VYX
$1.82B
$1.27M 3.12% 33,875
GILD icon
12
Gilead Sciences
GILD
$140B
$1.26M 3.08% +15,490 New +$1.26M
INTC icon
13
Intel
INTC
$107B
$1.25M 3.07% 32,845 +100 +0.3% +$3.81K
DEO icon
14
Diageo
DEO
$62.1B
$1.22M 2.99% 9,202 -40 -0.4% -$5.29K
AON icon
15
Aon
AON
$79.1B
$1.2M 2.94% 8,200 -100 -1% -$14.6K
CB icon
16
Chubb
CB
$110B
$1.16M 2.84% 8,111
CVX icon
17
Chevron
CVX
$324B
$1.14M 2.81% 9,735 +35 +0.4% +$4.11K
EMR icon
18
Emerson Electric
EMR
$74.3B
$1.12M 2.75% 17,790 +395 +2% +$24.8K
PFE icon
19
Pfizer
PFE
$141B
$1.08M 2.66% 30,325 -100 -0.3% -$3.57K
PG icon
20
Procter & Gamble
PG
$368B
$1.03M 2.53% 11,325
AAPL icon
21
Apple
AAPL
$3.45T
$933K 2.29% 6,056 -25 -0.4% -$3.85K
GE icon
22
GE Aerospace
GE
$292B
$933K 2.29% 38,590 +1,950 +5% +$47.1K
FLR icon
23
Fluor
FLR
$6.63B
$922K 2.26% 21,905 +2,395 +12% +$101K
BMY icon
24
Bristol-Myers Squibb
BMY
$96B
$905K 2.22% 14,200 -500 -3% -$31.9K
ABBV icon
25
AbbVie
ABBV
$372B
$894K 2.2% 10,057